FAQ
Answers to the questions that institutional buyers, family offices, defense primes, and counsel most commonly ask before engaging Industrial Spine Research.
You receive the complete thesis as a PDF (typically 25–40 pages, 12 sections plus 4 appendices), the underlying 10-sheet primary-source fact sheet as an xlsx workbook, three production-quality charts as 300 DPI PNGs, 30 days of direct email access to the analyst, and one 60-minute analyst call to be scheduled at your convenience. A right of first refusal applies for 18 months on any updates or refreshes to the thesis.
Yes — exclusive. Each thesis is sold once to one buyer. After purchase, the thesis is removed from the public catalog permanently. Industrial Spine Research retains the right to reference the thesis in firm-level marketing and in subsequent published research, but does not redistribute the underlying work product. The buyer is the sole holder of the integrated thesis package.
Yes, within your purchasing entity (the firm or fund identified at checkout) and its named affiliates. You may share the thesis with colleagues, advisors, and portfolio company management for the purpose of evaluating the commercial opportunity it describes. You may not publish, syndicate, or resell the thesis or any substantial portion of it. Full terms are in the Terms of Service.
Each thesis is priced inside the $25,000–$75,000 band on a weighted formula: 60% ISR aggregate score (out of 25), 25% total addressable market for the dependency, and 15% federal funding density. The price is fixed at publication and does not change for the life of the listing.
In limited circumstances, yes. For multi-thesis purchases, institutional buyers known to the firm, or structured commercialization partnerships, we will consider negotiated pricing. All negotiated discounts apply through Stripe Promotion Codes for clean audit trails. Contact us via the inquiry form to discuss.
MTS is a published academic framework for identifying, scoring, and prioritizing compound supply chain dependencies. It is documented in seven peer-reviewed papers at SSRN — one root paper, five sector extensions, and one policy white paper. See the Methodology page for the complete reading list.
Every claim in every thesis cites primary source — USGS, FDA, BARDA, GAO, executive orders, peer-reviewed literature, SEC filings, Federal Register. We do not cite aggregator outlets or unverified industry summaries. The fact sheet xlsx includes a dedicated source-citation worksheet (typically 20–30 numbered sources per thesis).
Immediate. Upon Stripe-confirmed payment, your account is provisioned with download access to the thesis, fact sheet, and chart pack. You will receive a confirmation email with a one-time sign-in link. Subsequent sign-ins use the same email-based magic-link flow.
Sold theses are removed from the public catalog but remain visible as social proof. We do not republish or resell. If a closely related dependency is of interest, you can commission a bespoke engagement — typically 90–120 days delivery for a custom thesis built to your specific commercialization target.
A Methodology Subscription does not grant access to sold or published theses. Instead it grants 30-day first-look access on every new thesis — subscribers can be the exclusive buyer 30 days before each thesis enters the public catalog. Subscription also includes quarterly methodology updates, monthly market briefings, and a 10–20% discount on any thesis purchase depending on tier.
Firm and Enterprise subscriptions are domain-based. The admin user purchases the subscription with their work email (e.g. @yourfirm.com); the firm domain is registered as the subscription account. Subsequent users who sign up with the same domain are automatically added to the account (up to 5 seats for Firm, unlimited for Enterprise). The admin manages invitations and seat allocation in the account panel.
Yes. Firm and Enterprise Methodology Subscriptions include a 7-day trial. The trial is non-renewable per domain. Individual subscriptions do not include a trial; the price point is set for a single named user.
Industrial Spine Research is an independent research firm founded by Robert J. Green, MBA, PhD ABD. The firm is structured as a publishing operation, not an investment advisor; we sell research products and do not manage capital. See the About page for analyst credentials and publication record.
No. Industrial Spine Research publishes research products. Nothing in any thesis, fact sheet, or chart pack constitutes investment, legal, tax, or accounting advice. Buyers must conduct their own diligence and consult their own qualified advisors before acting on any analysis. Full disclaimers are in our Terms of Service.
No. We are not a registered investment advisor (RIA) and we do not provide personalized investment advice. We publish independent research; all theses are advertised, sold, and delivered as standalone informational products. Our research is purchased by sophisticated institutional buyers who conduct their own investment analysis.
Because each thesis is sold exclusively and access cannot be reversed (the buyer obtains the work product immediately on payment), all sales of exclusive theses and pillar portfolios are final. Methodology Subscriptions may be canceled at any time during the 7-day trial (for Firm and Enterprise tiers) or pro-rated within 14 days of purchase (for any tier). Bespoke engagements are governed by the executed engagement letter.
Inquiries from prospective institutional buyers, counsel, and federal program officers are welcome.